Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Home
Alembic Pharmaceuticals Limited
Press Release May 04 2022
Business
May 4 2022
4 min read

Press Release May 04 2022

Alembic Pharmaceuticals Limited has informed the Exchange about press release dated 04-May-2022 titled Alembic Pharmaceuticals announces its wholly owned subsidiary, Aleor Dermaceuticals Limited receives USFDA Final Approval for Docosanol Cream, 10% (OTC)

View Attachment